Target Price | $26.01 |
Price | $7.38 |
Potential |
252.44%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target Bicycle Therapeutics Plc 2026 .
The average Bicycle Therapeutics Plc target price is $26.01.
This is
252.44%
register free of charge
$46.20
526.02%
register free of charge
$10.10
36.86%
register free of charge
|
|
A rating was issued by 19 analysts: 15 Analysts recommend Bicycle Therapeutics Plc to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bicycle Therapeutics Plc stock has an average upside potential 2026 of
252.44%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 35.28 | 30.74 |
30.76% | 12.88% | |
EBITDA Margin | -572.51% | -903.11% |
15.51% | 57.75% | |
Net Margin | -479.11% | -962.13% |
28.45% | 100.82% |
17 Analysts have issued a sales forecast Bicycle Therapeutics Plc 2025 . The average Bicycle Therapeutics Plc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Bicycle Therapeutics Plc EBITDA forecast 2025. The average Bicycle Therapeutics Plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Bicycle Therapeutics Plc Analysts have issued a net profit forecast 2025. The average Bicycle Therapeutics Plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.90 | -4.27 |
42.91% | 47.24% | |
P/E | negative | |
EV/Sales | negative |
16 Analysts have issued a Bicycle Therapeutics Plc forecast for earnings per share. The average Bicycle Therapeutics Plc EPS is
This results in the following potential growth metrics and future valuations:
Bicycle Therapeutics Plc...
Analyst | Rating | Action | Date |
---|---|---|---|
JMP Securities |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 06 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | May 02 2025 |
B. Riley Securities |
Locked
➜
Locked
|
Locked | May 02 2025 |
Analyst Rating | Date |
---|---|
Locked
JMP Securities:
Locked
➜
Locked
|
Aug 12 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 12 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 11 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 17 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 06 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
May 02 2025 |
Locked
B. Riley Securities:
Locked
➜
Locked
|
May 02 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.